Penbrook Management’s Viemed Healthcare VMD Stock Holding History

Penbrook Management’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.51M	Sell	275,948 -1,230	-0.4%	-$12.4K	1.48%	14
2026 Q2	$3.16M	Buy	277,178 +4,780	+2%	+$47.3K	2.02%	9
2026 Q1	$2.51M	Buy	272,398 +850	+0.3%	+$7.07K	1.9%	13
2025 Q4	$2.02M	Sell	271,548 -780	-0.3%	-$5.34K	1.39%	15
2025 Q3	$1.85M	Buy	272,328 +92,308	+51%	+$625K	1.29%	15
2025 Q2	$1.24M	Sell	180,020 -26,557	-13%	-$180K	0.94%	26
2025 Q1	$1.5M	Sell	206,577 -7,280	-3%	-$57.2K	1.14%	20
2024 Q4	$1.72M	Hold	213,857	–	–	1.17%	17
2024 Q3	$1.57M	Sell	213,857 -17,750	-8%	-$127K	1.02%	20
2024 Q2	$1.52M	Buy	231,607 +162,670	+236%	+$1.23M	0.93%	21
2024 Q1	$650K	Sell	68,937 -850	-1%	-$7.28K	0.4%	54
2023 Q4	$548K	Sell	69,787 -450	-0.6%	-$3.26K	0.37%	62
2023 Q3	$473K	Buy	70,237 +19,387	+38%	+$159K	0.35%	66
2023 Q2	$497K	Hold	50,850	–	–	0.36%	64
2023 Q1	$491K	Buy	+50,850	New	+$443K	0.38%	63

Other funds holding VMD

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

UIA

Ulland Investment Advisors Minneapolis, Minnesota $142M AUM 22.97% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

RPWA

Regent Peak Wealth Advisors Atlanta, Georgia $577M AUM 20.1% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Penbrook Management's VMD Position: Q3 2026 in Review

Penbrook Management reduced its Viemed Healthcare (VMD) stake by 0.44% in Q3 2026, selling an estimated $12.4K and leaving 275,948 shares worth $2.51M. The position accounts for 1.48% of the portfolio, ranked #14.

Penbrook Management first reported a position in VMD in Q1 2023 and has held it in 15 quarters since. The position peaked at $3.16M in Q2 2026. 17 funds tracked by Wall St. Rank hold VMD as of Q3 2026.

Penbrook Management held 275,948 shares of Viemed Healthcare worth $2.51M as of Q3 2026.
Penbrook Management sold 1,230 Viemed Healthcare shares in Q3 2026, an estimated $12.4K.
Viemed Healthcare made up 1.48% of Penbrook Management's portfolio in Q3 2026, its #14 holding.
Penbrook Management first reported a position in Viemed Healthcare in Q1 2023 and has held it in 15 quarters since.
Penbrook Management's Viemed Healthcare position peaked at $3.16M in Q2 2026.
17 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2026.

Based on Penbrook Management's 13F filing for Q3 2026, filed 16 Oct 2026.